406 related articles for article (PubMed ID: 8504050)
21. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
22. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
[TBL] [Abstract][Full Text] [Related]
23. The action spectrum between 320 and 400 nm for clearance of psoriasis by psoralen photochemotherapy.
Farr PM; Diffey BL; Higgins EM; Matthews JN
Br J Dermatol; 1991 May; 124(5):443-8. PubMed ID: 2039720
[TBL] [Abstract][Full Text] [Related]
24. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
[TBL] [Abstract][Full Text] [Related]
25. Effect of psoralen and ultraviolet A on platelet functioning: an in vitro and in vivo study.
Procaccini EM; Pandolfi G; Monfrecola G; Rotoli B
Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):4-7. PubMed ID: 1390123
[TBL] [Abstract][Full Text] [Related]
26. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
[TBL] [Abstract][Full Text] [Related]
27. Treatment of actinic prurigo with PUVA: mechanism of action.
Farr PM; Diffey BL
Br J Dermatol; 1989 Mar; 120(3):411-8. PubMed ID: 2713261
[TBL] [Abstract][Full Text] [Related]
28. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
Calzavara-Pinton P
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
[TBL] [Abstract][Full Text] [Related]
29. DNA repair elicited by UVB during PUVA therapy for psoriasis.
Bishop SC; Abel EA
Arch Dermatol Res; 1985; 278(1):25-30. PubMed ID: 4096527
[TBL] [Abstract][Full Text] [Related]
30. Comparative studies on the tolerance to photoinduced cutaneous inflammatory reactions by psoralen and rose bengal.
Kumar JR; Haberman HF; Ranadive NS
J Photochem Photobiol B; 1997 Feb; 37(3):245-53. PubMed ID: 9085568
[TBL] [Abstract][Full Text] [Related]
31. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
32. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
33. 5-Methoxy psoralen, etretinate, and UVA for psoriasis.
Lane-Brown M
Int J Dermatol; 1987 Dec; 26(10):655-9. PubMed ID: 3429102
[TBL] [Abstract][Full Text] [Related]
34. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
Lowe NJ; Weingarten D; Bourget T; Moy LS
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
[TBL] [Abstract][Full Text] [Related]
35. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
Aubin F; Makki S; Humbert P; Muret P; Agache P
Arch Dermatol Res; 1994; 286(1):30-4. PubMed ID: 8141609
[TBL] [Abstract][Full Text] [Related]
36. Photoprotection due to pigmentation and epidermal thickness after repeated exposure to ultraviolet light and psoralen plus ultraviolet A therapy.
Bech-Thomsen N; Wulf HC
Photodermatol Photoimmunol Photomed; 1995; 11(5-6):213-8. PubMed ID: 8738717
[TBL] [Abstract][Full Text] [Related]
37. Quantitative studies on UVA-induced erythema in human skin.
Diffey BL; Farr PM; Oakley AM
Br J Dermatol; 1987 Jul; 117(1):57-66. PubMed ID: 3651335
[TBL] [Abstract][Full Text] [Related]
38. Minimum erythema dose determination in individuals of skin type V and VI with diffuse reflectance spectroscopy.
Kollias N; Baqer A; Sadiq I
Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):249-54. PubMed ID: 7727281
[TBL] [Abstract][Full Text] [Related]
39. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis.
Ortel B; Perl S; Kinaciyan T; Calzavara-Pinton PG; Hönigsmann H
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):736-40. PubMed ID: 8227546
[TBL] [Abstract][Full Text] [Related]
40. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
Collins P; Rogers S
Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
